Compare with DYNEMIC PRODUCTS - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GENERIC PHARMASEC vs DYNEMIC PRODUCTS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    GENERIC PHARMASEC DYNEMIC PRODUCTS GENERIC PHARMASEC/
DYNEMIC PRODUCTS
 
P/E (TTM) x 86.4 22.8 379.6% View Chart
P/BV x 8.6 4.1 211.6% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 GENERIC PHARMASEC   DYNEMIC PRODUCTS
EQUITY SHARE DATA
    GENERIC PHARMASEC
Mar-21
DYNEMIC PRODUCTS
Mar-21
GENERIC PHARMASEC/
DYNEMIC PRODUCTS
5-Yr Chart
Click to enlarge
High Rs17550 3.0%   
Low Rs797 7.6%   
Sales per share (Unadj.) Rs0.8181.5 0.4%  
Earnings per share (Unadj.) Rs025.2 0.2%  
Cash flow per share (Unadj.) Rs028.2 0.2%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs0.7138.0 0.5%  
Shares outstanding (eoy) m276.8611.33 2,443.6%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x15.61.8 873.3%   
Avg P/E ratio x263.512.8 2,050.9%  
P/CF ratio (eoy) x260.911.5 2,275.7%  
Price / Book Value ratio x16.02.3 684.9%  
Dividend payout %00-   
Avg Mkt Cap Rs m3,3143,662 90.5%   
No. of employees `000NANA-   
Total wages/salary Rs m284 2.2%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m2132,056 10.4%  
Other income Rs m36 53.7%   
Total revenues Rs m2162,062 10.5%   
Gross profit Rs m12434 2.8%  
Depreciation Rs m034 0.3%   
Interest Rs m023 0.0%   
Profit before tax Rs m15383 3.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m398 2.6%   
Profit after tax Rs m13285 4.4%  
Gross profit margin %5.621.1 26.5%  
Effective tax rate %16.725.6 65.2%   
Net profit margin %5.913.9 42.6%  
BALANCE SHEET DATA
Current assets Rs m2681,125 23.8%   
Current liabilities Rs m72942 7.6%   
Net working cap to sales %92.18.9 1,035.5%  
Current ratio x3.71.2 313.4%  
Inventory Days Days14817 849.5%  
Debtors Days Days128,898,635734 17,555,856.2%  
Net fixed assets Rs m102,386 0.4%   
Share capital Rs m277113 244.4%   
"Free" reserves Rs m-701,450 -4.8%   
Net worth Rs m2071,563 13.2%   
Long term debt Rs m0966 0.0%   
Total assets Rs m2783,511 7.9%  
Interest coverage xNM17.8-  
Debt to equity ratio x00.6 0.0%  
Sales to assets ratio x0.80.6 130.8%   
Return on assets %4.58.8 51.6%  
Return on equity %6.118.2 33.4%  
Return on capital %7.316.0 45.6%  
Exports to sales %066.6 0.0%   
Imports to sales %013.8 0.0%   
Exports (fob) Rs mNA1,370 0.0%   
Imports (cif) Rs mNA285 0.0%   
Fx inflow Rs m01,370 0.0%   
Fx outflow Rs m0285 0.0%   
Net fx Rs m01,086 0.0%   
CASH FLOW
From Operations Rs m-21481 -4.4%  
From Investments Rs m-14-988 1.4%  
From Financial Activity Rs m45494 9.1%  
Net Cashflow Rs m10-2 -461.4%  

Share Holding

Indian Promoters % 0.0 29.8 -  
Foreign collaborators % 60.0 0.0 -  
Indian inst/Mut Fund % 0.0 0.3 -  
FIIs % 0.0 0.3 -  
ADR/GDR % 0.0 0.0 -  
Free float % 40.0 70.3 57.0%  
Shareholders   17,121 16,567 103.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare GENERIC PHARMASEC With:   ORGANIC COAT  JAYS.DYESTUF  DYNAMIC IND.  SUDARSHAN CHEMICAL  JD ORGOCHEM  



Today's Market

SGX Nifty Down 52 Points; Indicates Negative Opening for Indian Stock Markets(SGX Nifty)

The SGX Nifty opened on a negative note today. At 8:15 am, it was trading down by 52 points, or 0.3% lower at 17,397 levels.

Related Views on News

DYNEMIC PRODUCTS 2020-21 Annual Report Analysis (Annual Result Update)

Oct 29, 2021 | Updated on Oct 29, 2021

Here's an analysis of the annual report of DYNEMIC PRODUCTS for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of DYNEMIC PRODUCTS. Also includes updates on the valuation of DYNEMIC PRODUCTS.

Ami Organics Stock Makes Impressive Debut on Bourses. Lists at 49% Premium (Views On News)

Sep 14, 2021

Shares of Ami Organics makes a strong debut on the stock exchange. Did you bid for the IPO?

Chemplast Sanmar Makes Flat Debut as IPO Frenzy Fizzles Out (Views On News)

Aug 24, 2021

The grey market had indicated a flat listing for shares of Chemplast Sanmar ahead of its debut.

Understanding Aarti Industries' Demerger (Views On News)

Aug 20, 2021

Will the pharma unit's demerger unlock value for shareholders?

What Next for Devyani, Zomato, & Tatva Chintan Pharma After Stellar IPO Gains? (Views On News)

Aug 20, 2021

What's the outlook for Devyani, Zomato, and Tatva Chintan Pharma after robust listings?

More Views on News

Most Popular

Infosys vs TCS: Which is Better?(Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

This Multibagger Stock Zooms 20% After Dolly Khanna Buys Stake(Views On News)

Nov 24, 2021

Shares of this edible oil company zoomed over 50% in three days after ace investor bought around 1% stake.

6 Popular Stocks that Turned into Penny Stocks(Views On News)

Nov 27, 2021

A look at popular stocks that crashed big time and never recovered, i.e. which went from 'Multibaggers to Multibeggers'.

MobiKwik IPO Opens for Subscription Soon. Key Things to Know Before Subscribing.(Views On News)

Nov 20, 2021

The Rs 19 bn issue is set to hit the market soon.

5 Indian Companies Embracing Blockchain Technology(Views On News)

Nov 23, 2021

Blockchain adoption in India was slow in the past. Now, the technology is being well received.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

GENERIC PHARMASEC SHARE PRICE


Dec 3, 2021 09:22 AM

TRACK GENERIC PHARMASEC

  • Track your investment in GENERIC PHARMASEC with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON GENERIC PHARMASEC

GENERIC PHARMASEC 5-YR ANALYSIS

COMPARE GENERIC PHARMASEC WITH

MARKET STATS